# Construal Level as a Novel Pathway for Affect Regulation and Cancer Control

> **NCT04620915** · NA · COMPLETED · sponsor: **University of Oregon** · enrollment: 300 (actual)

## Conditions studied

- Smoking Cessation
- Smoking Reduction
- Cancer

## Interventions

- **BEHAVIORAL:** High-level construal
- **BEHAVIORAL:** Down-regulation of craving for cigarettes
- **BEHAVIORAL:** Up-regulation of goal energization

## Key facts

- **NCT ID:** NCT04620915
- **Lead sponsor:** University of Oregon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-11
- **Primary completion:** 2025-08-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2026-05-08

## Collaborators

- Ohio State University

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04620915

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04620915, "Construal Level as a Novel Pathway for Affect Regulation and Cancer Control". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04620915. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*